Premium
Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial
Author(s) -
Zhang Zeyu,
Xia Fada,
Wang Wenlong,
Jiang Bo,
Yao Lei,
Huang Yun,
Li Xinying
Publication year - 2021
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26557
Subject(s) - ambulatory , medicine , thyroidectomy , randomized controlled trial , thyroid carcinoma , anxiety , incidence (geometry) , depression (economics) , mental health , surgery , thyroid , psychiatry , physics , optics , economics , macroeconomics
Background Currently, no randomized controlled trial has been performed to investigate the safety profiles, economic benefit and mental health of ambulatory thyroidectomy in patients with papillary thyroid carcinoma (PTC). Methods Patients diagnosed with PTC were enrolled in this study and were randomly assigned to ambulatory group and control group. The safety profiles, economic benefit and mental health were investigated. Results Four hundred and eleven patients completed the study. There was no significant difference in demographic or tumor index. The incidence of complications was not significantly different ( P = .631). The economic cost was significantly lower ( P < .001) and hospitalization was significantly shorter ( P < .001) in ambulatory group. No significant difference was shown in depression ( P = .758) and stress disorder ( P = .390). However, the ambulatory group showed a higher point of anxiety ( P < .001). Conclusion The ambulatory thyroidectomy is safe in patients with PTC, with significant benefits of economic cost and hospitalization.